FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4212958103> ?p ?o ?g. }

• W4212958103 abstract "Introduction The complex interplay between the autonomic nervous system, renin-angiotensin-aldosterone system (RAAS), and immunity contributes to the pathogenesis of hypertension in diabetes mellitus. The objective of this study was to investigate and compare the effect of azilsartan and telmisartan on insulin resistance and metabolic biomarkers in patients with both hypertension and type 2 diabetes mellitus. Methods The present study was a prospective, randomized, active-controlled, open-label, parallel-group clinical trial. Patients with grade I or II essential hypertension with type 2 diabetes mellitus were randomized into two groups of 25 patients each. Baseline evaluation of homeostasis model assessment-insulin resistance (HOMA-IR), plasma glucose, insulin, leptin and adiponectin levels, and systolic and diastolic blood pressure (SBP and DBP) of patients was done. Patients were reassessed after 12 weeks of drug therapy with azilsartan 40 mg OD (once daily) or telmisartan 40 mg OD. Results The mean changes in HOMA-IR from the baseline at the end of 12 weeks of treatment were 0.15 (−0.64, 0.94.52) in the azilsartan group and 0.32 (−0.61, 1.26) in the telmisartan group. The mean difference in the changes from the baseline in HOMA-IR between the two groups was 0.3 (−0.87, 1.48), which was not statistically significant. No statistically significant changes were observed between the two groups in metabolic biomarkers (leptin: -0.84, CI: -4.83 to 3.14, and adiponectin: -0.12, CI: -0.62 to 0.37). Systolic (SBP) and diastolic blood pressure (DBP) decreased at the end of the 12-week treatment in both the groups; however, there was no significant difference between the two groups (SBP: -2.6, CI: -10.35 to 5.1, and DBP: -3.0, CI: -7.7 to 1.7). Conclusion Neither azilsartan nor telmisartan had any significant effects on insulin resistance and metabolic biomarkers after 12 weeks of drug therapy in hypertension patients associated with type 2 diabetes mellitus. However, they showed a comparable antihypertensive effect. The adverse effects observed were mild in nature, and their incidence was comparable between the two groups." @default.
• W4212958103 created "2022-02-24" @default.
• W4212958103 creator A5019157318 @default.
• W4212958103 creator A5045366024 @default.
• W4212958103 creator A5068224315 @default.
• W4212958103 creator A5070153237 @default.
• W4212958103 creator A5072940887 @default.
• W4212958103 creator A5081418700 @default.
• W4212958103 date "2022-02-16" @default.
• W4212958103 modified "2023-09-26" @default.
• W4212958103 title "Comparative Study of the Effects of Azilsartan and Telmisartan on Insulin Resistance and Metabolic Biomarkers in Essential Hypertension Associated With Type 2 Diabetes Mellitus" @default.
• W4212958103 cites W131003225 @default.
• W4212958103 cites W1511683349 @default.
• W4212958103 cites W1942801754 @default.
• W4212958103 cites W1963549723 @default.
• W4212958103 cites W1985560249 @default.
• W4212958103 cites W1993489156 @default.
• W4212958103 cites W1994181754 @default.
• W4212958103 cites W2026710308 @default.
• W4212958103 cites W2041415987 @default.
• W4212958103 cites W2048359273 @default.
• W4212958103 cites W2055539224 @default.
• W4212958103 cites W2057442959 @default.
• W4212958103 cites W2061528318 @default.
• W4212958103 cites W2076870989 @default.
• W4212958103 cites W2100653932 @default.
• W4212958103 cites W2102258085 @default.
• W4212958103 cites W2117377148 @default.
• W4212958103 cites W2126125759 @default.
• W4212958103 cites W2132669925 @default.
• W4212958103 cites W2162307589 @default.
• W4212958103 cites W2162506832 @default.
• W4212958103 cites W2182150538 @default.
• W4212958103 cites W2315088918 @default.
• W4212958103 cites W2560231498 @default.
• W4212958103 cites W2586133222 @default.
• W4212958103 cites W2926498455 @default.
• W4212958103 doi "https://doi.org/10.7759/cureus.22301" @default.
• W4212958103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35350513" @default.
• W4212958103 hasPublicationYear "2022" @default.
• W4212958103 type Work @default.
• W4212958103 citedByCount "1" @default.
• W4212958103 countsByYear W42129581032023 @default.
• W4212958103 crossrefType "journal-article" @default.
• W4212958103 hasAuthorship W4212958103A5019157318 @default.
• W4212958103 hasAuthorship W4212958103A5045366024 @default.
• W4212958103 hasAuthorship W4212958103A5068224315 @default.
• W4212958103 hasAuthorship W4212958103A5070153237 @default.
• W4212958103 hasAuthorship W4212958103A5072940887 @default.
• W4212958103 hasAuthorship W4212958103A5081418700 @default.
• W4212958103 hasBestOaLocation W42129581031 @default.
• W4212958103 hasConcept C126322002 @default.
• W4212958103 hasConcept C134018914 @default.
• W4212958103 hasConcept C2776782570 @default.
• W4212958103 hasConcept C2777097880 @default.
• W4212958103 hasConcept C2777391703 @default.
• W4212958103 hasConcept C2778525890 @default.
• W4212958103 hasConcept C2778535154 @default.
• W4212958103 hasConcept C2779306644 @default.
• W4212958103 hasConcept C2779716603 @default.
• W4212958103 hasConcept C2780578515 @default.
• W4212958103 hasConcept C2910068830 @default.
• W4212958103 hasConcept C555293320 @default.
• W4212958103 hasConcept C71924100 @default.
• W4212958103 hasConcept C84393581 @default.
• W4212958103 hasConceptScore W4212958103C126322002 @default.
• W4212958103 hasConceptScore W4212958103C134018914 @default.
• W4212958103 hasConceptScore W4212958103C2776782570 @default.
• W4212958103 hasConceptScore W4212958103C2777097880 @default.
• W4212958103 hasConceptScore W4212958103C2777391703 @default.
• W4212958103 hasConceptScore W4212958103C2778525890 @default.
• W4212958103 hasConceptScore W4212958103C2778535154 @default.
• W4212958103 hasConceptScore W4212958103C2779306644 @default.
• W4212958103 hasConceptScore W4212958103C2779716603 @default.
• W4212958103 hasConceptScore W4212958103C2780578515 @default.
• W4212958103 hasConceptScore W4212958103C2910068830 @default.
• W4212958103 hasConceptScore W4212958103C555293320 @default.
• W4212958103 hasConceptScore W4212958103C71924100 @default.
• W4212958103 hasConceptScore W4212958103C84393581 @default.
• W4212958103 hasLocation W42129581031 @default.
• W4212958103 hasLocation W42129581032 @default.
• W4212958103 hasLocation W42129581033 @default.
• W4212958103 hasOpenAccess W4212958103 @default.
• W4212958103 hasPrimaryLocation W42129581031 @default.
• W4212958103 hasRelatedWork W138803513 @default.
• W4212958103 hasRelatedWork W1982589044 @default.
• W4212958103 hasRelatedWork W2031083656 @default.
• W4212958103 hasRelatedWork W2066062695 @default.
• W4212958103 hasRelatedWork W2082140668 @default.
• W4212958103 hasRelatedWork W2120688902 @default.
• W4212958103 hasRelatedWork W2136767406 @default.
• W4212958103 hasRelatedWork W2375944679 @default.
• W4212958103 hasRelatedWork W2589899659 @default.
• W4212958103 hasRelatedWork W3028839963 @default.
• W4212958103 isParatext "false" @default.
• W4212958103 isRetracted "false" @default.
• W4212958103 workType "article" @default.